These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22804914)

  • 21. Shrink that frown! Botulinum toxin therapy is lifting the face of psychiatry.
    Wollmer MA; Neumann I; Magid M; Kruger TH
    G Ital Dermatol Venereol; 2018 Aug; 153(4):540-548. PubMed ID: 29667799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Controversy: botulinum toxin, does it prevent cutaneous aging?].
    Cohen-Letessier A
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S89-91. PubMed ID: 19576492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin. The Newport Beach experience.
    Fulton JE
    Dermatol Surg; 1998 Nov; 24(11):1219-24. PubMed ID: 9834742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.
    Kaltreider SA; Kennedy RH; Woog JJ; Bradley EA; Custer PL; Meyer DR; ;
    Ophthalmology; 2005 Jun; 112(6):1159-67. PubMed ID: 15936443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis.
    Spencer JM; Gordon M; Goldberg DJ
    J Cosmet Laser Ther; 2002 Mar; 4(1):19-23. PubMed ID: 12079633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum A toxin for glabellar wrinkles. Dose and response.
    Hankins CL; Strimling R; Rogers GS
    Dermatol Surg; 1998 Nov; 24(11):1181-3. PubMed ID: 9834736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Facial anatomy and botulinum toxin: the muscular balances].
    Trevidic P; Cauchois R; Ingallina F
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S61-6. PubMed ID: 19576487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulinum toxin A in the treatment of the wrinkles in the upper third of the face].
    Gassia V
    Ann Dermatol Venereol; 2008 Feb; 135 Suppl 3():S175-80. PubMed ID: 18342124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines.
    Guerrissi J; Sarkissian P
    Ann Plast Surg; 1997 Nov; 39(5):447-53. PubMed ID: 9374139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle Insertion and Strength of the Muscle Contraction as Guidelines to Enhance Duration of the Botulinum Toxin Effect in the Upper Face.
    Abramo AC
    Aesthetic Plast Surg; 2018 Oct; 42(5):1379-1387. PubMed ID: 29987485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of depression with botulinum toxin A: a case series.
    Finzi E; Wasserman E
    Dermatol Surg; 2006 May; 32(5):645-9; discussion 649-50. PubMed ID: 16706759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.
    Sadick NS
    Dermatol Surg; 2003 May; 29(5):501-7; discussion 507. PubMed ID: 12752518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection.
    Pribitkin EA; Greco TM; Goode RL; Keane WM
    Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):321-6. PubMed ID: 9076240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Retrospective Study of Chinese-Specific Glabellar Contraction Patterns.
    Hsieh DM; Zhong S; Tong X; Yuan C; Yang L; Yao AY; Zhou C; Wu Y
    Dermatol Surg; 2019 Nov; 45(11):1406-1413. PubMed ID: 30789513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin injection techniques in the lower third and middle of the face, the neck and the décolleté: the "Nefertiti lift"].
    Gassia V; Beylot C; Béchaux S; Michaud T
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S111-8. PubMed ID: 19576476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periocular botulinum toxin.
    Flynn TC
    Clin Dermatol; 2003; 21(6):498-504. PubMed ID: 14759583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facing depression with botulinum toxin: a randomized controlled trial.
    Wollmer MA; de Boer C; Kalak N; Beck J; Götz T; Schmidt T; Hodzic M; Bayer U; Kollmann T; Kollewe K; Sönmez D; Duntsch K; Haug MD; Schedlowski M; Hatzinger M; Dressler D; Brand S; Holsboer-Trachsler E; Kruger TH
    J Psychiatr Res; 2012 May; 46(5):574-81. PubMed ID: 22364892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.
    Sadick NS; Faacs
    Dermatol Surg; 2002 Sep; 28(9):817-21. PubMed ID: 12269875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.